INMED PHARMACEUTICALS INC INM

US Healthcare Pharmaceutical Preparations
$1.56
-1.9%
52w: $0.61 – $3.87

Latest 13F among current holders filed 1 month ago (May 15, 2026)

Price — last 12 months

research preview data
0.612.243.87
Jun 20, 2025 Jul 2, 2026
Institutional holders
9
+2 QoQ
13F value
$206K
-14.4% QoQ
Smart-money holders
0
signal tier ≥ 2
New smart buyers
0
Q1 2026

Institutional value by quarter

$227K
Q4 2024
$13K
Q1 2025
$29K
Q2 2025
$665K
Q3 2025
$241K
Q4 2025
$206K
Q1 2026

Number of holders

6
Q4 2024
6
Q1 2025
8
Q2 2025
9
Q3 2025
7
Q4 2025
9
Q1 2026

Who owns INM?

Q1 2026 filings
FundTypeSharesValue% of fundChange
SABBY MANAGEMENT, LLC Other220.3K$142K2.5%+9.2%
CITADEL ADVISORS LLC Multistrat pod47.0K$30K0.0%New
Virtu Financial LLC Market maker20.0K$13K0.0%New
TWO SIGMA SECURITIES, LLC Market maker18.7K$12K0.0%New
UBS Group AG Bank broker8.1K$5K0.0%+2040.1%
Private Wealth Management Group, LLC Wealth advisor5.0K$3K0.0%New
SBI Securities Co., Ltd. Diversified mechanical300$1930.0%Held
Federation des caisses Desjardins du Quebec Diversified mechanical2$20.0%Held
Banque Cantonale Vaudoise Other6$00.0%Held

Exits are not a bearish signal: our backtest shows stocks specialists exit keep outperforming for 3+ quarters — selling usually means profit-taking, not a forecast.